URL of this page: https://medlineplus.gov/druginfo/natural/905.html

Reishi Mushroom

What is it?

Reishi mushroom (Ganoderma lucidum) is a bitter-tasting fungus with no proven health benefits. It is thought to have some effects on the immune system.

Reishi mushroom is used for Alzheimer disease, cancer, diabetes, cold sores, and many other conditions, but there is no good scientific evidence to support these uses.

How effective is it?

Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, Ineffective, and Insufficient Evidence to Rate.

The effectiveness ratings for REISHI MUSHROOM are as follows:

Possibly ineffective for...

  • High levels of cholesterol or other fats (lipids) in the blood (hyperlipidemia). Taking reishi mushroom by mouth doesn't seem to lower cholesterol levels in people with diabetes or high cholesterol.
There is interest in using reishi mushroom for a number of other purposes, but there isn't enough reliable information to say whether it might be helpful.

How does it work?

Are there safety concerns?

When taken by mouth: Reishi mushroom extract is possibly safe when used for up to one year. Powdered whole reishi mushroom is possibly safe when used for up to 16 weeks. Reishi mushroom can cause dizziness, dry mouth, itching, nausea, stomach upset, and rash.

Special precautions & warnings:

Pregnancy and breast-feeding: There isn't enough reliable information to know if reishi mushroom is safe to use when pregnant or breast feeding. Stay on the safe side and avoid use.

Bleeding disorders: High doses of reishi mushroom might increase the risk of bleeding in some people with certain bleeding disorders.

Surgery: High doses of reishi mushroom might increase the risk of bleeding in some people if used before or during surgery. Stop using reishi mushroom at least 2 weeks before a scheduled surgery.

Are there interactions with medications?

Moderate
Be cautious with this combination.
Medications for diabetes (Antidiabetes drugs)
Reishi mushroom might lower blood sugar levels. Taking reishi mushroom along with diabetes medications might cause blood sugar to drop too low. Monitor your blood sugar closely.
Medications for high blood pressure (Antihypertensive drugs)
Reishi mushroom might lower blood pressure. Taking reishi mushroom along with medications that lower blood pressure might cause blood pressure to go too low. Monitor your blood pressure closely.
Medications that slow blood clotting (Anticoagulant / Antiplatelet drugs)
Reishi mushroom might slow blood clotting. Taking reishi mushroom along with medications that also slow blood clotting might increase the risk of bruising and bleeding.

Are there interactions with herbs and supplements?

Herbs and supplements that might lower blood pressure
Reishi mushroom might lower blood pressure. Taking it with other supplements that have the same effect might cause blood pressure to drop too much. Examples of supplements with this effect include andrographis, casein peptides, L-arginine, niacin, and stinging nettle.
Herbs and supplements that might lower blood sugar
Reishi mushroom might lower blood sugar. Taking it with other supplements with similar effects might lower blood sugar too much. Examples of supplements with this effect include aloe, bitter melon, cassia cinnamon, chromium, and prickly pear cactus.
Herbs and supplements that might slow blood clotting
Reishi mushroom might slow blood clotting and increase the risk of bleeding. Taking it with other supplements with similar effects might increase the risk of bleeding in some people. Examples of supplements with this effect include garlic, ginger, ginkgo, nattokinase, and Panax ginseng.

Are there interactions with foods?

There are no known interactions with foods.

What dose is used?

Reishi mushroom has most often been used by adults in doses of 1400-5400 mg by mouth daily, usually in divided doses. Reishi mushroom extracts have also been used in lower doses. Speak with a healthcare provider to find out what dose might be best for a specific condition.

Other names

Basidiomycetes Mushroom, Champignon Basidiomycète, Champignon d'Immortalité, Champignon Reishi, Champignons Reishi, Ganoderma, Ganoderma lucidum, Hongo Reishi, Ling Chih, Ling Zhi, Mannentake, Mushroom, Mushroom of Immortality, Mushroom of Spiritual Potency, Red Reishi, Reishi, Reishi Antler Mushroom, Reishi Rouge, Rei-Shi, Spirit Plant.

Methodology

To learn more about how this article was written, please see the Natural Medicines Comprehensive Database methodology.

References

  1. Zhong L, Yan P, Lam WC, et al. Coriolus versicolor and Ganoderma lucidum related natural products as an adjunct therapy for cancers: a systematic review and meta-analysis of randomized controlled trials. Front Pharmacol 2019;10:703. View abstract.
  2. Wang GH, Wang LH, Wang C, Qin LH. Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study.Medicine (Baltimore). 2018 May;97:e0636. doi: 10.1097/MD.0000000000010636. View abstract.
  3. Wu DT, Deng Y, Chen LX. Evaluation on quality consistency of Ganoderma lucidum dietary supplements collected in the United States. Sci Rep. 2017 Aug 10;7:7792. doi: 10.1038/s41598-017-06336-3. View abstract.
  4. Ríos JL, Andújar I, Recio MC, Giner RM. Lanostanoids from fungi: a group of potential anticancer compounds. J Nat Prod. 2012 Nov 26;75:2016-44. View abstract.
  5. Hennicke F, Cheikh-Ali Z, Liebisch T, Maciá-Vicente JG, Bode HB, Piepenbring M. Distinguishing commercially grown Ganoderma lucidum from Ganoderma lingzhi from Europe and East Asia on the basis of morphology, molecular phylogeny, and triterpenic acid profiles. Phytochemistry. 2016 Jul;127:29-37. View abstract.
  6. Zhao H, Zhang Q, Zhao L, Huang X, Wang J, Kang X. Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial. Evid Based Complement Alternat Med. 2012;2012:809614. View abstract.
  7. Noguchi M, Kakuma T, Tomiyasu K, Yamada A, Itoh K, Konishi F, Kumamoto S, Shimizu K, Kondo R, Matsuoka K. Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms. Asian J Androl. 2008 Sep;10:777-85. View abstract.
  8. Noguchi M, Kakuma T, Tomiyasu K, Kurita Y, Kukihara H, Konishi F, Kumamoto S, Shimizu K, Kondo R, Matsuoka K. Effect of an extract of Ganoderma lucidum in men with lower urinary tract symptoms: a double-blind, placebo-controlled randomized and dose-ranging study. Asian J Androl. 2008 Jul;10:651-8. View abstract.
  9. Klupp NL, Chang D, Hawke F, Kiat H, Cao H, Grant SJ, Bensoussan A. Ganoderma lucidum mushroom for the treatment of cardiovascular risk factors. Cochrane Database Syst Rev. 2015 Feb 17;2:CD007259. View abstract.
  10. Hijikata Y, Yamada S, Yasuhara A. Herbal mixtures containing the mushroom Ganoderma lucidum improve recovery time in patients with herpes genitalis and labialis. J Altern Complement Med. 2007 Nov;13:985-7. View abstract.
  11. Donatini B. Control of oral human papillomavirus (HPV) by medicinal mushrooms, Trametes versicolor and Ganoderma lucidum: a preliminary clinical trial. Int J Med Mushrooms. 2014;16:497-8. View abstract.
  12. Mizuno, T. Bioactive biomolecules of mushrooms: food function and medicinal effect of mushroom fungi. Fd Rev Internat 1995;11:7-21.
  13. Jin H, Zhang G, Cao X, and et al. Treatment of hypertension by linzhi combined with hypotensor and its effects on arterial, arteriolar and capillary pressure and microcirculation. In: Niimi H, Xiu RJ, Sawada T, and et al. Microcirculatory Approach to Asian Traditional Medicine. New York: Elsevier Science;1996.
  14. Gao, Y., Lan, J., Dai, X., Ye, J., and Zhou, S. A Phase I/II Study of Ling Zhi Mushroom Ganoderma lucidum(W.Curt: Fr.) Lloyd (Aphyllophoromycetideae) Extract in Patients with Type II Diabetes Mellitus. International Journal of Medicinal Mushrooms 2004;6.
  15. Gao, Y., Chen, G., Dai, X., Ye, J., and Zhou, S. A Phase I/II Study of Ling Zhi Mushroom Ganoderma lucidum(W.Curt: Fr.) Lloyd (Aphyllophoromycetideae) Extract in Patients with Coronary Heart Disease. International Journal of Medicinal Mushrooms 2004.
  16. Gao, Y., Zhou, S., Chen, G., Dai, X., Ye, J., and Gao, H. A Phase I/II Study of a Ganoderma lucidum(Curt.:Fr.) P. Karst. (Ling Zhi, Reishi Mushroom) Extract in Patients with Chronic Hepatitis BÂ. InternationalJournal ofMedicinalMushrooms 2002;4:2321-7.
  17. Gao, Y., Zhou, S., Chen, G., Dai, X., and Ye, J. A Phase I/II Study of a
  18. Gao, Y., Dai, X., Chen, G., Ye, J., and Zhou, S. A Randomized, Placebo-Controlled, Multicenter Study of Ganoderma lucidum (W.Curt: Fr.) Lloyd (Aphyllophoromycetideae) Polysaccharides (Ganopoly®) in Patients with Advanced Lung Cancer. International Journal of Medicinal Mushrooms 2003;5.
  19. Zhang X, Jia Y Li Q Niu S Zhu S Shen C. Clinical curative effect investigation of Lingzhi tablet on lung cancer. Chinese Traditional Patent Medicine 2000;22:486-488.
  20. Yan B, Wei Y Li Y. Effect of Laojunxian Lingzhi oral liquid combined with chemotherapy on non-parvicellular lung cancer at stage II and III. Traditional Chinese Drug Research & Clinical Pharmacology 1998;9:78-80.
  21. Leng K, LuM. Investigation of ZhengQing Lingzhi liquid as adjuvant treatment on patients with colon cancer. Journal of Guiyang Medical College 2003;28:1.
  22. He W, Yi J. Study of clinical efficacy of Lingzhi spore capsule on tumour patients with chemotherapy/radiotherapy. Clinical Journal of Traditional Chinese Medicine 1997;9:292-293.
  23. Park, E. J., Ko, G., Kim, J., and Sohn, D. H. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction. Biol Pharm Bull. 1997;20:417-420. View abstract.
  24. Kawagishi, H., Mitsunaga, S., Yamawaki, M., Ido, M., Shimada, A., Kinoshita, T., Murata, T., Usui, T., Kimura, A., and Chiba, S. A lectin from mycelia of the fungus Ganoderma lucidum. Phytochemistry 1997;44:7-10. View abstract.
  25. van der Hem, L. G., van der Vliet, J. A., Bocken, C. F., Kino, K., Hoitsma, A. J., and Tax, W. J. Prolongation of allograft survival with Ling Zhi-8, a new immunosuppressive drug. Transplant.Proc. 1994;26:746. View abstract.
  26. Kanmatsuse, K., Kajiwara, N., Hayashi, K., Shimogaichi, S., Fukinbara, I., Ishikawa, H., and Tamura, T. [Studies on Ganoderma lucidum. I. Efficacy against hypertension and side effects]. Yakugaku Zasshi 1985;105:942-947. View abstract.
  27. Shimizu, A., Yano, T., Saito, Y., and Inada, Y. Isolation of an inhibitor of platelet aggregation from a fungus, Ganoderma lucidum. Chem Pharm Bull.(Tokyo) 1985;33:3012-3015. View abstract.
  28. Kabir, Y., Kimura, S., and Tamura, T. Dietary effect of Ganoderma lucidum mushroom on blood pressure and lipid levels in spontaneously hypertensive rats (SHR). J Nutr Sci Vitaminol.(Tokyo) 1988;34:433-438. View abstract.
  29. Morigiwa, A., Kitabatake, K., Fujimoto, Y., and Ikekawa, N. Angiotensin converting enzyme-inhibitory triterpenes from Ganoderma lucidum. Chem Pharm Bull.(Tokyo) 1986;34:3025-3028. View abstract.
  30. Hikino, H. and Mizuno, T. Hypoglycemic actions of some heteroglycans of Ganoderma lucidum fruit bodies. Planta Med 1989;55:385. View abstract.
  31. Jin, X., Ruiz, Beguerie J., Sze, D. M., and Chan, G. C. Ganoderma lucidum (Reishi mushroom) for cancer treatment. Cochrane.Database.Syst.Rev. 2012;6:CD007731. View abstract.
  32. Chu, T. T., Benzie, I. F., Lam, C. W., Fok, B. S., Lee, K. K., and Tomlinson, B. Study of potential cardioprotective effects of Ganoderma lucidum (Lingzhi): results of a controlled human intervention trial. Br.J.Nutr. 2012;107:1017-1027. View abstract.
  33. Oka, S., Tanaka, S., Yoshida, S., Hiyama, T., Ueno, Y., Ito, M., Kitadai, Y., Yoshihara, M., and Chayama, K. A water-soluble extract from culture medium of Ganoderma lucidum mycelia suppresses the development of colorectal adenomas. Hiroshima J.Med.Sci. 2010;59:1-6. View abstract.
  34. Liu, J., Shiono, J., Shimizu, K., Kukita, A., Kukita, T., and Kondo, R. Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor. Bioorg.Med.Chem.Lett. 4-15-2009;19:2154-2157. View abstract.
  35. Zhuang, S. R., Chen, S. L., Tsai, J. H., Huang, C. C., Wu, T. C., Liu, W. S., Tseng, H. C., Lee, H. S., Huang, M. C., Shane, G. T., Yang, C. H., Shen, Y. C., Yan, Y. Y., and Wang, C. K. Effect of citronellol and the Chinese medical herb complex on cellular immunity of cancer patients receiving chemotherapy/radiotherapy. Phytother.Res. 2009;23:785-790. View abstract.
  36. Seto, S. W., Lam, T. Y., Tam, H. L., Au, A. L., Chan, S. W., Wu, J. H., Yu, P. H., Leung, G. P., Ngai, S. M., Yeung, J. H., Leung, P. S., Lee, S. M., and Kwan, Y. W. Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice. Phytomedicine. 2009;16:426-436. View abstract.
  37. Lin, C. N., Tome, W. P., and Won, S. J. Novel cytotoxic principles of Formosan Ganoderma lucidum. J Nat Prod 1991;54:998-1002. View abstract.
  38. Li, E. K., Tam, L. S., Wong, C. K., Li, W. C., Lam, C. W., Wachtel-Galor, S., Benzie, I. F., Bao, Y. X., Leung, P. C., and Tomlinson, B. Safety and efficacy of Ganoderma lucidum (lingzhi) and San Miao San supplementation in patients with rheumatoid arthritis: a double-blind, randomized, placebo-controlled pilot trial. Arthritis Rheum 10-15-2007;57:1143-1150. View abstract.
  39. Wanmuang, H., Leopairut, J., Kositchaiwat, C., Wananukul, W., and Bunyaratvej, S. Fatal fulminant hepatitis associated with Ganoderma lucidum (Lingzhi) mushroom powder. J Med Assoc Thai. 2007;90:179-181. View abstract.
  40. Ni, T., Hu, Y., Sun, L., Chen, X., Zhong, J., Ma, H., and Lin, Z. Oral route of mini-proinsulin-expressing Ganoderma lucidum decreases blood glucose level in streptozocin-induced diabetic rats. Int.J.Mol.Med. 2007;20:45-51. View abstract.
  41. Cheuk, W., Chan, J. K., Nuovo, G., Chan, M. K., and Fok, M. Regression of gastric large B-Cell lymphoma accompanied by a florid lymphoma-like T-cell reaction: immunomodulatory effect of Ganoderma lucidum (Lingzhi)? Int J Surg Pathol 2007;15:180-186. View abstract.
  42. Chen, T. W., Wong, Y. K., and Lee, S. S. [In vitro cytotoxicity of Ganoderma lucidum on oral cancer cells]. Chung Hua I.Hsueh Tsa Chih (Taipei) 1991;48:54-58. View abstract.
  43. Hsu, H. Y., Hua, K. F., Lin, C. C., Lin, C. H., Hsu, J., and Wong, C. H. Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways. J.Immunol. 11-15-2004;173:5989-5999. View abstract.
  44. Lu, Q. Y., Jin, Y. S., Zhang, Q., Zhang, Z., Heber, D., Go, V. L., Li, F. P., and Rao, J. Y. Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett. 12-8-2004;216:9-20. View abstract.
  45. Hong, K. J., Dunn, D. M., Shen, C. L., and Pence, B. C. Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells. Phytother.Res. 2004;18:768-770. View abstract.
  46. Lu, Q. Y., Sartippour, M. R., Brooks, M. N., Zhang, Q., Hardy, M., Go, V. L., Li, F. P., and Heber, D. Ganoderma lucidum spore extract inhibits endothelial and breast cancer cells in vitro. Oncol.Rep. 2004;12:659-662. View abstract.
  47. Cao, Q. Z. and Lin, Z. B. Antitumor and anti-angiogenic activity of Ganoderma lucidum polysaccharides peptide. Acta Pharmacol.Sin. 2004;25:833-838. View abstract.
  48. Jiang, J., Slivova, V., Valachovicova, T., Harvey, K., and Sliva, D. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int.J.Oncol. 2004;24:1093-1099. View abstract.
  49. Lieu, C. W., Lee, S. S., and Wang, S. Y. The effect of Ganoderma lucidum on induction of differentiation in leukemic U937 cells. Anticancer Res. 1992;12:1211-1215. View abstract.
  50. Berger, A., Rein, D., Kratky, E., Monnard, I., Hajjaj, H., Meirim, I., Piguet-Welsch, C., Hauser, J., Mace, K., and Niederberger, P. Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and minipigs. Lipids Health Dis. 2-18-2004;3:2. View abstract.
  51. Wachtel-Galor, S., Tomlinson, B., and Benzie, I. F. Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br.J.Nutr. 2004;91:263-269. View abstract.
  52. Iwatsuki, K., Akihisa, T., Tokuda, H., Ukiya, M., Oshikubo, M., Kimura, Y., Asano, T., Nomura, A., and Nishino, H. Lucidenic acids P and Q, methyl lucidenate P, and other triterpenoids from the fungus Ganoderma lucidum and their inhibitory effects on Epstein-Barr virus activation. J.Nat.Prod. 2003;66:1582-1585. View abstract.
  53. Wachtel-Galor, S., Szeto, Y. T., Tomlinson, B., and Benzie, I. F. Ganoderma lucidum ('Lingzhi'); acute and short-term biomarker response to supplementation. Int.J.Food Sci.Nutr. 2004;55:75-83. View abstract.
  54. Sliva, D., Sedlak, M., Slivova, V., Valachovicova, T., Lloyd, F. P., Jr., and Ho, N. W. Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J.Altern.Complement Med. 2003;9:491-497. View abstract.
  55. Hsu, M. J., Lee, S. S., Lee, S. T., and Lin, W. W. Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum. Br.J.Pharmacol. 2003;139:289-298. View abstract.
  56. Xiao, G. L., Liu, F. Y., and Chen, Z. H. [Clinical observation on treatment of Russula subnigricans poisoning patients by Ganoderma lucidum decoction]. Zhongguo Zhong.Xi.Yi.Jie.He.Za Zhi. 2003;23:278-280. View abstract.
  57. Sliva, D., Labarrere, C., Slivova, V., Sedlak, M., Lloyd, F. P., Jr., and Ho, N. W. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem.Biophys.Res.Commun. 11-8-2002;298:603-612. View abstract.
  58. Hu, H., Ahn, N. S., Yang, X., Lee, Y. S., and Kang, K. S. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int.J.Cancer 11-20-2002;102:250-253. View abstract.
  59. Futrakul, N., Boongen, M., Tosukhowong, P., Patumraj, S., and Futrakul, P. Treatment with vasodilators and crude extract of Ganoderma lucidum suppresses proteinuria in nephrosis with focal segmental glomerulosclerosis. Nephron 2002;92:719-720. View abstract.
  60. Zhong, L., Jiang, D., and Wang, Q. [Effects of Ganoderma lucidum (Leyss ex Fr) Karst compound on the proliferation and differentiation of K562 leukemic cells]. Hunan.Yi.Ke.Da.Xue.Xue.Bao. 1999;24:521-524. View abstract.
  61. Gao, J. J., Min, B. S., Ahn, E. M., Nakamura, N., Lee, H. K., and Hattori, M. New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem.Pharm.Bull.(Tokyo) 2002;50:837-840. View abstract.
  62. Ma, J., Ye, Q., Hua, Y., Zhang, D., Cooper, R., Chang, M. N., Chang, J. Y., and Sun, H. H. New lanostanoids from the mushroom Ganoderma lucidum. J.Nat.Prod. 2002;65:72-75. View abstract.
  63. Min, B. S., Gao, J. J., Hattori, M., Lee, H. K., and Kim, Y. H. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. Planta Med. 2001;67:811-814. View abstract.
  64. Lee, J. M., Kwon, H., Jeong, H., Lee, J. W., Lee, S. Y., Baek, S. J., and Surh, Y. J. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res 2001;15:245-249. View abstract.
  65. Zhu, H. S., Yang, X. L., Wang, L. B., Zhao, D. X., and Chen, L. Effects of extracts from sporoderm-broken spores of Ganoderma lucidum on HeLa cells. Cell Biol.Toxicol. 2000;16:201-206. View abstract.
  66. Eo, S. K., Kim, Y. S., Lee, C. K., and Han, S. S. Possible mode of antiviral activity of acidic protein bound polysaccharide isolated from Ganoderma lucidum on herpes simplex viruses. J Ethnopharmacol. 2000;72:475-481. View abstract.
  67. Su, C., Shiao, M., and Wang, C. Potentiation of ganodermic acid S on prostaglandin E-induced cyclic AMP elevation in human platelets. Thromb.Res 7-15-2000;99:135-145. View abstract.
  68. Yun, T. K. Update from Asia. Asian studies on cancer chemoprevention. Ann.N.Y Acad.Sci. 1999;889:157-192. View abstract.
  69. Mizushina, Y., Takahashi, N., Hanashima, L., Koshino, H., Esumi, Y., Uzawa, J., Sugawara, F., and Sakaguchi, K. Lucidenic acid O and lactone, new terpene inhibitors of eukaryotic DNA polymerases from a basidiomycete, Ganoderma lucidum. Bioorg.Med.Chem. 1999;7:2047-2052. View abstract.
  70. Kim, K. C. and Kim, I. G. Ganoderma lucidum extract protects DNA from strand breakage caused by hydroxyl radical and UV irradiation. Int J Mol.Med 1999;4:273-277. View abstract.
  71. Olaku, O. and White, J. D. Herbal therapy use by cancer patients: a literature review on case reports. Eur.J.Cancer 2011;47:508-514. View abstract.
  72. Haniadka, R., Popouri, S., Palatty, P. L., Arora, R., and Baliga, M. S. Medicinal plants as antiemetics in the treatment of cancer: a review. Integr.Cancer Ther. 2012;11:18-28. View abstract.
  73. Gao Y, Zhou S, Jiang W, et al. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest 2003;32:201-15. View abstract.
  74. Yuen JW, Gohel MD. Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer 2005;53:11-7. View abstract.
  75. Sun J, He H, Xie BJ. Novel antioxidant peptides from fermented mushroom Ganoderma lucidum. J Agric Food Chem 2004;52:6646-52. View abstract.
  76. Kwok Y, Ng KFJ, Li, CCF, et al. A prospective, randomized, double-blind, placebo-controlled study of the platelet and global hemostatic effects of Ganoderma lucidum (Ling-Zhi) in healthy volunteers. Anesth Analg 2005;101:423-6. View abstract.
  77. van der Hem LG, van der Vliet JA, Bocken CF, et al. Ling Zhi-8: studies of a new immunomodulating agent. Transplantation 1995;60:438-43. View abstract.
  78. Yoon SY, Eo SK, Kim YS, et al. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm Res 1994;17:438-42. View abstract.
  79. Kim DH, Shim SB, Kim NJ, et al. Beta-glucuronidase-inhibitory activity and hepatoprotective effect of Ganoderma lucidum. Biol Pharm Bull 1999;22:162-4. View abstract.
  80. Lee SY, Rhee HM. Cardiovascular effects of mycelium extract of Ganoderma lucidum: inhibition of sympathetic outflow as a mechanism of its hypotensive action. Chem Pharm Bull (Tokyo) 1990;38:1359-64. View abstract.
  81. Hikino H, Ishiyama M, Suzuki Y, et al. Mechanisms of hypoglycemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. Planta Med 1989;55:423-8. View abstract.
  82. Komoda Y, Shimizu M, Sonoda Y, et al. Ganoderic acid and its derivatives as cholesterol synthesis inhibitors. Chem Pharm Bull (Tokyo) 1989;37:531-3. View abstract.
  83. Hijikata Y, Yamada S. Effect of Ganoderma lucidum on postherpetic neuralgia. Am J Chin Med 1998;26:375-81. View abstract.
  84. Kim HS, Kacew S, Lee BM. In vitro chemopreventive effects of plant polysaccharides (Aloe barbadensis miller, Lentinus edodes, Ganoderma lucidum and Coriolus versicolor). Carcinogenesis 1999;20:1637-40. View abstract.
  85. Wang SY, Hsu ML, Hsu HC, et al. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 1997;70:699-705. View abstract.
  86. Kim RS, Kim HW, Kim BK. Suppressive effects of Ganoderma lucidum on proliferation of peripheral blood mononuclear cells. Mol Cells 1997;7:52-7. View abstract.
  87. el-Mekkawy S, Meselhy MR, Nakamura N, et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochem 1998;49:1651-7. View abstract.
  88. Min BS, Nakamura N, Miyashiro H, et al. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharm Bull (Tokyo) 1998;46:1607-12. View abstract.
  89. Singh AB, Gupta SK, Pereira BM, Prakash D. Sensitization to Ganoderma lucidum in patients with respiratory allergy in India. Clin Exp Allergy 1995;25:440-7. View abstract.
  90. Gau JP, Lin CK, Lee SS, et al. The lack of antiplatelet effect of crude extracts from ganoderma lucidum on HIV-positive hemophiliacs. Am J Chin Med 1990;18:175-9. View abstract.
  91. Wasser SP, Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 1999;19:65-96. View abstract.
  92. Tao J, Feng KY. Experimental and clinical studies on inhibitory effect of ganoderma lucidum on platelet aggregation. J Tongji Med Univ 1990;10:240-3. View abstract.
  93. McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.
Last reviewed - 08/13/2021